The proteomics technology provider, backed by Nan Fung, iCarbonX, Novartis, Otsuka and Quest Diagnostics, has now secured $485m in total.

The ophthalmic biotherapeutics developer has completed a series A round co-led by Eli Lilly unit Lilly Asia Ventures nine months after it was founded.

Summation Health Ventures returned for a series C round that lifted the healthcare communication system provider's total funding to $45m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

M2P-Labs, a supplier of microbioreactors based on RWTH Aachen intellectual property, has agreed to an acquisition by Beckman Coulter Life Sciences.

Telus Pollinator Fund for Good is equipped with $76.5m to invest in developers of technology that can promote positive social and environmental impact.

Baidu-backed Subtle Medical produces AI-driven medical imaging software intended to work across different healthcare systems, and has raised $12.2m.

Takeda Ventures and Astellas Venture Management both backed cell therapy developer Catamaran as it emerged from stealth.

George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.